Equities research analysts predict that Israel Chemicals Ltd (NYSE:ICL) will post $0.09 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Israel Chemicals’ earnings. Israel Chemicals posted earnings per share of $0.11 in the same quarter last year, which would suggest a negative year-over-year growth rate of 18.2%. The company is expected to report its next earnings report on Wednesday, February 13th.
According to Zacks, analysts expect that Israel Chemicals will report full year earnings of $0.37 per share for the current fiscal year. For the next financial year, analysts forecast that the business will report earnings of $0.38 per share. Zacks’ earnings per share calculations are an average based on a survey of analysts that that provide coverage for Israel Chemicals.
Israel Chemicals (NYSE:ICL) last released its earnings results on Thursday, November 1st. The basic materials company reported $0.10 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.01. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. The company had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.38 billion. During the same quarter last year, the business earned $0.09 EPS. The business’s revenue was down 4.8% on a year-over-year basis.
Several hedge funds and other institutional investors have recently made changes to their positions in ICL. Artemis Investment Management LLP acquired a new stake in shares of Israel Chemicals in the third quarter valued at about $49,871,000. FMR LLC acquired a new stake in shares of Israel Chemicals in the third quarter valued at about $25,668,000. Altshuler Shaham Ltd lifted its stake in shares of Israel Chemicals by 441.5% in the third quarter. Altshuler Shaham Ltd now owns 1,370,810 shares of the basic materials company’s stock valued at $8,390,000 after purchasing an additional 1,117,665 shares during the period. Allianz Asset Management GmbH acquired a new stake in shares of Israel Chemicals in the third quarter valued at about $4,463,000. Finally, Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of Israel Chemicals by 2,050.6% in the second quarter. Clal Insurance Enterprises Holdings Ltd now owns 649,982 shares of the basic materials company’s stock valued at $2,990,000 after purchasing an additional 619,759 shares during the period. Hedge funds and other institutional investors own 8.10% of the company’s stock.
Shares of ICL stock traded up $0.07 during mid-day trading on Friday, hitting $6.30. The stock had a trading volume of 64,140 shares, compared to its average volume of 220,547. Israel Chemicals has a fifty-two week low of $3.85 and a fifty-two week high of $6.90. The stock has a market capitalization of $8.08 billion, a PE ratio of 20.32, a price-to-earnings-growth ratio of 1.76 and a beta of 1.07. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.73 and a current ratio of 1.34.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Tuesday, December 4th will be paid a $0.051 dividend. This is a boost from Israel Chemicals’s previous quarterly dividend of $0.04. The ex-dividend date of this dividend is Monday, December 3rd. This represents a $0.20 annualized dividend and a dividend yield of 3.24%. Israel Chemicals’s dividend payout ratio (DPR) is 32.26%.
Israel Chemicals Company Profile
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
Featured Article: Intrinsic Value and Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.